1. Home
  2. SABS vs DUOT Comparison

SABS vs DUOT Comparison

Compare SABS & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • DUOT
  • Stock Information
  • Founded
  • SABS 2014
  • DUOT 1990
  • Country
  • SABS United States
  • DUOT United States
  • Employees
  • SABS N/A
  • DUOT N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • DUOT Computer Software: Prepackaged Software
  • Sector
  • SABS Health Care
  • DUOT Technology
  • Exchange
  • SABS Nasdaq
  • DUOT Nasdaq
  • Market Cap
  • SABS 23.9M
  • DUOT 24.2M
  • IPO Year
  • SABS N/A
  • DUOT N/A
  • Fundamental
  • Price
  • SABS $2.76
  • DUOT $3.83
  • Analyst Decision
  • SABS Strong Buy
  • DUOT Strong Buy
  • Analyst Count
  • SABS 5
  • DUOT 1
  • Target Price
  • SABS $12.40
  • DUOT $6.00
  • AVG Volume (30 Days)
  • SABS 112.4K
  • DUOT 55.9K
  • Earning Date
  • SABS 11-11-2024
  • DUOT 11-12-2024
  • Dividend Yield
  • SABS N/A
  • DUOT N/A
  • EPS Growth
  • SABS N/A
  • DUOT N/A
  • EPS
  • SABS N/A
  • DUOT N/A
  • Revenue
  • SABS $2,780,084.00
  • DUOT $5,638,027.00
  • Revenue This Year
  • SABS N/A
  • DUOT $66.43
  • Revenue Next Year
  • SABS N/A
  • DUOT $83.75
  • P/E Ratio
  • SABS N/A
  • DUOT N/A
  • Revenue Growth
  • SABS N/A
  • DUOT N/A
  • 52 Week Low
  • SABS $2.16
  • DUOT $1.94
  • 52 Week High
  • SABS $10.50
  • DUOT $5.74
  • Technical
  • Relative Strength Index (RSI)
  • SABS 51.65
  • DUOT 67.66
  • Support Level
  • SABS $2.36
  • DUOT $3.05
  • Resistance Level
  • SABS $3.21
  • DUOT $4.34
  • Average True Range (ATR)
  • SABS 0.24
  • DUOT 0.33
  • MACD
  • SABS 0.02
  • DUOT 0.09
  • Stochastic Oscillator
  • SABS 47.06
  • DUOT 67.10

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains while they are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

Share on Social Networks: